+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
WANBURY

Wanbury Share Price

 

 

Wanbury live price: ₹267.35. It opened at ₹279 vs previous close ₹275; intraday high/low: ₹284/₹265. The 50 & 200 DMA stand at ₹260.63/₹250.25.

Wanbury Performance

  • Today's Low
  • ₹265
  • Today's High
  • ₹284
  • 52 Week Low
  • ₹162
  • 52 Week High
  • ₹321
  • Open Price₹279
  • Previous Close₹275
  • Volume102,887
  • 50 DMA₹260.63
  • 100 DMA₹254.47
  • 200 DMA₹250.25

Wanbury Chart

Investment Returns

  • Over 1 Month + 3.4%
  • Over 3 Month + 7.03%
  • Over 6 Month + 12.66%
  • Over 1 Year -14.37%

Smart Investing Starts Here Start SIP with Wanbury for Steady Growth!

Invest Now

Wanbury Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 14.1
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 934
  • P/B Ratio
  • 6.5
  • Average True Range
  • 15.77
  • EPS
  • 19.95
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.98
  • RSI
  • 51.2
  • MFI
  • 49.84

Latest Stock News Updates

This pharma co's stock rose on launching iron supplement to treat anemia

Wanbury share price climbed 2.4 per cent after the company launched iron supplement 'Wanbury C RED'

India's pharma sector spared from US tariff hikes as Wanbury plans investor visit

Wanbury Limited is preparing for an investors and analysts plant visit on April 10 following major plant upgrades completed in Q3

Wanbury to launch new iron supplement and Ketamine API

The shares of Wanbury Limited were trading at 266.01 up by 25.09 or 10.41 per cent on the NSE today at 2.18 pm

Wanbury Financials

Wanbury Technicals

EMA & SMA

Current Price
₹267.35
-7.2 (-2.62%)
pointer
  • Bearish Moving Average 1
  • Bullish Moving Average 15
  • 20 Day
  • ₹265.80
  • 50 Day
  • ₹260.60
  • 100 Day
  • ₹254.50
  • 200 Day
  • ₹250.20

Resistance and Support

271.95 Pivot Speed
  • R3 298.90
  • R2 291.45
  • R1 279.40
  • S1 259.90
  • S2 252.45
  • S3 240.40

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Wanbury manufactures and markets pharmaceutical products, focusing on active pharmaceutical ingredients (APIs) and formulations. The company serves global markets with a range of therapeutic solutions in areas like anti-diabetics, pain management, and gastrointestinal treatments.

Wanbury has an operating revenue of Rs. 650.27 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 9% is okay, ROE of 45% is exceptional. The company has a high debt to equity of 102%, which can be a reason to worry. The stock from a technical standpoint is comfortably placed above its key moving averages, around 6% and 10% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 93 which is a GREAT score indicating consistency in earnings, a RS Rating of 67 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 55 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Wanbury Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-29 Audited Results (Revised)
2026-02-05 Quarterly Results
2025-11-13 Quarterly Results
2025-08-04 Quarterly Results
2025-05-15 Audited Results

Wanbury Shareholding Pattern

43.02%
0%
0.59%
0%
42.16%
14.23%

Wanbury FAQs

Wanbury share price is ₹267 As on 16 June, 2026 | 01:14

The Market Cap of Wanbury is ₹934.1 Cr As on 16 June, 2026 | 01:14

The P/E ratio of Wanbury is 14.1 As on 16 June, 2026 | 01:14

The PB ratio of Wanbury is 6.5 As on 16 June, 2026 | 01:14

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23